Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Nov 08, 2007	EDAP Launches Ablatherm-HIFU RPP Service At First South African Site EDAP Launches Ablatherm-HIFU RPP Service At First South African Site LYON, France, Nov. 8, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces, together with their South African distributors, Intamed, the	View HTML EDAP Launches Ablatherm-HIFU RPP Service At First South African Site 12.6 KB
Toggle Summary Nov 07, 2007	EDAP's Ablatherm-HIFU Recognized as the Only HIFU Robotic Option At Global Urology Meeting EDAP Technology Added Alongside Robotic Devices for Prostate Cancer	View HTML EDAP's Ablatherm-HIFU Recognized as the Only HIFU Robotic Option At Global Urology Meeting 11.7 KB
Toggle Summary Nov 05, 2007	EDAP TMS S.A. Closes $20 Million Placement to Fully Fund Its U.S. Clinical Studies Company Now in Position to Roll-Out Its U.S. Strategy	View HTML EDAP TMS S.A. Closes $20 Million Placement to Fully Fund Its U.S. Clinical Studies 13.6 KB
Toggle Summary Oct 31, 2007	Ablatherm-HIFU Launches a New RPP Site in Spain RPP Service available in Madrid at ICUA clinic	View HTML Ablatherm-HIFU Launches a New RPP Site in Spain 15.8 KB
Toggle Summary Oct 30, 2007	EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies LYON, France , Oct. 30 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP) the global leader in High Intensity Focused Ultrasound treatment of prostate cancer announces that it has entered into a securities purchase	View HTML EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies 11.5 KB
Toggle Summary Sep 19, 2007	EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook Lyon, France, September 19, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced a series of events centered around the DGU Conference in	View HTML EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook 13.7 KB
Toggle Summary Sep 10, 2007	EDAP Launches Enhanced Communication Plans at SIU Paris Congress EDAP Launches Enhanced Communication Plans at SIU Paris Congress LYON, France , Sept. 10 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and a major global provider of stone breaking products,	View HTML EDAP Launches Enhanced Communication Plans at SIU Paris Congress 16.9 KB
Toggle Summary Aug 31, 2007	Vanderbilt Announces Participation in Ablatherm Study Vanderbilt-Ingram Cancer Center recently issued the following press release announcing its participation in the US Clinical Trial Study of the Ablatherm-HIFU device from EDAP.	View HTML Vanderbilt Announces Participation in Ablatherm Study 12.3 KB
Toggle Summary Aug 30, 2007	EDAP TMS S.A. 2007 Second Quarter Revenues Increase European Growth Continues, HIFU Division Returns to Profitability Retains Experienced North American Prostate Cancer Leader to Drive USA Programs Lyon, France, August 30, 2007 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer	View HTML EDAP TMS S.A. 2007 Second Quarter Revenues Increase 157.7 KB
Toggle Summary Aug 27, 2007	Recent US News & World Report Feature Highlights HIFU as Future of Prostate Cancer Therapy Recent US News & World Report Feature Highlights HIFU as Future of Prostate Cancer Therapy A recent article found in US News & World Report highlights HIFU and robotic surgery as key treatments of the future in the fight against early stage prostate cancer.	View HTML Recent US News & World Report Feature Highlights HIFU as Future of Prostate Cancer Therapy 18.9 KB